Related Experiment Videos
N-methylation underlying Parkinson's disease.
Kazuo Matsubara1, Koji Aoyama, Manabu Suno
1Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical College, Asahikawa 078-8510, Japan. kmatsuba@asahikawa-med.ac.jp
Neurotoxicology and Teratology
|August 30, 2002
Summary
Parkinson's disease may be linked to toxins like MPTP. Increased N-methylation activity, particularly of beta-carbolines, might activate neurotoxins, contributing to Parkinson's disease pathogenesis.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Parkinson's disease (PD) pathogenesis is hypothesized to involve environmental or endogenous toxins.
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) serves as a model for toxin-induced neurodegeneration.
- Endogenous MPTP analogs, like beta-carbolines (betaCs) and tetrahydroisoquinolines, are implicated in PD.
Purpose of the Study:
- To investigate the role of N-methylation in the bioactivation of endogenous neurotoxins in Parkinson's disease.
- To explore the potential link between N-methyltransferase activity and PD development.
Main Methods:
- Administered beta-carbolines to C57/BL mice to assess neurotoxic effects.
- Measured dopamine levels in the striatum and midbrain of mice.
- Analyzed N(1)-methyl-nicotinamide excretion and nicotinamide N-methyltransferase (NNMT) protein levels in younger PD patients and controls.
Main Results:
- BetaCs induced bradykinesia and decreased dopamine in mice, suggesting neurotoxicity.
- Younger PD patients showed significantly higher N(1)-methyl-nicotinamide excretion and NNMT protein levels compared to controls.
- Evidence suggests enhanced N-methylation ability for azaheterocyclic amines in PD pathogenesis.
Conclusions:
- Excess N-methylation activity, particularly of beta-carbolines, may contribute to Parkinson's disease pathogenesis.
- The role of cytochrome P450 or aldehyde oxidase in detoxifying these endogenous neurotoxins appears minimal in PD etiology.